Trudy M. Krause, DrPH

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

This study explored the statistical association of key social determinants of health with specific health outcomes to validate impact and then created weighted categorical matrices.